Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-038488
Filing Date
2019-06-21
Accepted
2019-06-21 16:40:37
Documents
1
Period of Report
2019-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4154
  Complete submission text file 0001209191-19-038488.txt   5599
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OVASCIENCE, INC. 9 FOURTH AVENUE WALTHAM MA 02451
Business Address
Owens Julia C. (Reporting) CIK: 0001760219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 19911985